|
市場調查報告書
新的流行性感冒疫苗開發機會
Is There Commercial Opportunity in the Development of a New Influenza Vaccine?
|
本報告已在2011年12月21日停止出版。
流行性感冒每年流行，對健康造成重大的威脅。 WHO 指出今後還有可能出現大流行。預防感冒流行最好的方法就是接種疫苗，但還存在一部份疫苗效果不佳、生產能力有限等問題。
專門於醫療產業廣泛調查工作的美國調查公司 Decision Resources Inc. （總公司：麻薩諸塞州），針對新的流行性感冒疫苗的開發機會進行調查分析，經系統整理後出版報告書 "Is There Commercial Opportunity in the Development of a New Influenza Vaccine?" 。
本報告書內容包括：全球的流感趨勢與目前可購得疫苗的優點與缺點、為改良現存疫苗企業研究的技術、流感疫苗市場今後的展望等。共計 17 頁的內容綱要摘記如下：
流行性感冒的威脅
關於流行性感冒
目前針對流行性感冒的預防與治療
流感疫苗開發之新對策
- 利用細胞培養來生產
- Adjuvanted 疫苗
- 新的藥品投遞系統
- 萬能疫苗
流感疫苗的商機
Abstract
In This Issue.
Influenza is a significant health issue. Influenza epidemics occur yearly, and
recently, health groups such as the World Health Organization and the Centers
for Disease Control and Prevention have raised the possibility of an influenza
pandemic. The U.S. Office of Health and Human Services estimates that, without
intervention, a pandemic could cause the deaths of almost 2 million people in
the United States and require the hospitalization of up to 10 million. Most
health officials agree that the best course of action in preventing an
epidemic or pandemic is vaccination. Current vaccines are generally considered
safe and efficacious, but they are not as efficacious in some high-risk
populations, and production capacity is limited. In this report, we examine
the worldwide health burden that influenza represents and discuss H5N1, a
current influenza strain that could cause the next pandemic. We compare the
advantages and disadvantages of available vaccines and describe technologies
that companies are investigating in an effort to improve on existing vaccines.
Finally, we discuss the outlook for the influenza vaccine market.
Table of Contents
The Flu Threat
About the Influenza Virus
- Virus Characteristics
- Influenza Epidemics and Pandemics
- H5N1
Current Prevention and Treatment of Influenza
- Inactivated Influenza Vaccines
- Live Attenuated Influenza Vaccines
Novel Approaches to Influenza Vaccine Development
- Cell Culture Manufacturing
- Adjuvanted Vaccines
- New Delivery Systems
- Universal Vaccine
Commercial Opportunities for Influenza Vaccines
- An Expanding Market
- Finding Success: Potential of the Novel Approaches
|
